ArticleOncotarget2015

SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.

Yizhou Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.